Pd-Rx Pharmaceutical's market value is the price at which a share of Pd-Rx Pharmaceutical trades on a public exchange. It measures the collective expectations of Pd Rx Pharmaceutical investors about its performance. Pd-Rx Pharmaceutical is trading at 3.33 as of the 27th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 3.33. With this module, you can estimate the performance of a buy and hold strategy of Pd Rx Pharmaceutical and determine expected loss or profit from investing in Pd-Rx Pharmaceutical over a given investment horizon. Check out Pd-Rx Pharmaceutical Correlation, Pd-Rx Pharmaceutical Volatility and Pd-Rx Pharmaceutical Alpha and Beta module to complement your research on Pd-Rx Pharmaceutical.
Please note, there is a significant difference between Pd-Rx Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pd-Rx Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pd-Rx Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pd-Rx Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pd-Rx Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pd-Rx Pharmaceutical.
0.00
10/29/2025
No Change 0.00
0.0
In 2 months and 31 days
01/27/2026
0.00
If you would invest 0.00 in Pd-Rx Pharmaceutical on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Pd Rx Pharmaceutical or generate 0.0% return on investment in Pd-Rx Pharmaceutical over 90 days. Pd-Rx Pharmaceutical is related to or competes with Sweet Earth, Interpace Biosciences, and Rapid Nutrition. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the h... More
Pd-Rx Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pd-Rx Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pd Rx Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pd-Rx Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pd-Rx Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Pd-Rx Pharmaceutical historical prices to predict the future Pd-Rx Pharmaceutical's volatility.
Pd-Rx Pharmaceutical appears to be slightly risky, given 3 months investment horizon. Pd Rx Pharmaceutical retains Efficiency (Sharpe Ratio) of 0.12, which implies the firm had a 0.12 % return per unit of price deviation over the last 3 months. We have found eighteen technical indicators for Pd-Rx Pharmaceutical, which you can use to evaluate the volatility of the company. Please evaluate Pd-Rx Pharmaceutical's market risk adjusted performance of (4.46), and Information Ratio of 0.1136 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pd-Rx Pharmaceutical holds a performance score of 9. The company owns a Beta (Systematic Risk) of -0.0668, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pd-Rx Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Pd-Rx Pharmaceutical is likely to outperform the market. Please check Pd-Rx Pharmaceutical's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and rate of daily change , to make a quick decision on whether Pd-Rx Pharmaceutical's current price history will revert.
Auto-correlation
-0.3
Weak reverse predictability
Pd Rx Pharmaceutical has weak reverse predictability. Overlapping area represents the amount of predictability between Pd-Rx Pharmaceutical time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pd Rx Pharmaceutical price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Pd-Rx Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.3
Spearman Rank Test
0.63
Residual Average
0.0
Price Variance
0.05
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.